Effectiveness of vero cell inactivated vaccine against severe acute respiratory infections (SARI) in Sibu, Malaysia: A retrospective test-negative design

• 主要な著者: Teck-Hock Toh (著者), Yang-Yang Qi (著者), Sook-Min Yong (著者), Jeffrey Soon-Yit Lee (著者), Nur Fatin Liyana (著者), Raymond Yon-Han See (著者), Jo-Hun Teh (著者), Aw-Zien Toh (著者), Lin Naing (著者), Kamilah Dahian (著者), Jun-Wei Liew (著者), Caisha Nivenia Mose (著者), Malvina Zi-Qing Yong (著者), Ngiik-Jing Ling (著者), Diana Wang-Sing Chua (著者), Wee-Wei Ling (著者), Nanthakumar Thirunavukkarasu (著者), Mohd Raili Suhaili (著者), Jie-Lai Xia (著者), John Clemens (著者), Xuan-Yi Wang (著者)
• フォーマット: 図書
• 出版事項: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

The effectiveness of the vero cell inactivated vaccine (CoronaVac®) against severe acute respiratory infection (‎SARI)‎ caused by SARS-CoV-2 in the real world was assessed. A matched test-negative case-control design was employed using the web-based national information system, as well as the hospit...